Refine by
Coronary Lesions Equipment & Supplies
6 equipment items found
Manufactured by:Biosensors International Group, Ltd. based inSingapore, SINGAPORE
Only the abluminal surface of the stent receives SMS treatment, allowing BA9™ to be contained within the micro-structured surface and delivered with high specificity to the vessel wall of the coronary lesions. The SMS process allows for an increased surface area for a uniform dose of BA9 to be delivered to the target lesion. With no need ...
Manufactured by:Hantech Medical Device Co.,Ltd based inNingbo, CHINA
Rapide is a rapid exchange pre-dilation PTCA catheter that creates new treatment options for difficult and challenging coronary lesions. Designed specifically for the most calcified of vessels it features state-of-the-art technology Lower Profile for ease of ...
Manufactured by:QT Vascular Ltd. based in, SINGAPORE
The pillows and grooves of the Chocolate® platform were designed to minimize vessel wall trauma. This unique platform has been demonstrated to reduce flow limiting dissections and bail-out stenting. Chocolate Touch® is coated with the drug paclitaxel for improved long-term outcomes. It is indicated to treat peripheral vascular disease and does not require ...
Manufactured by:amg International GmbH based inWinsen, GERMANY
The ARTHOSPico is a multicellular Cobalt-Chromium stent that offers strength, stability, and flexibility for treating the most difficult lesions. The Co-Cr Stent is indicated for patients with coronary heart disease. It is inserted in coronary vessels with a diameter of 2.0 to 4.0 mm. It is used for the treatment of de-novo and restenotic ...
Manufactured by:P+F Products + Features GMBH based inVienna, AUSTRIA
The EFIL+ Sirolimus Eluting Stent System is a combination product comprised of two regulated components: a device (a coronary stent system) and a drug product (a formulation of Sirolimus contained in a polymer coating) pre mounted on balloon catheter between two platinum iridium radio opaque marker bands. EFIL+ uses a validated formulation of low dose Sirolimus (1.30µg/mm ) timed to elute ...
Manufactured by:CeloNova BioSciences, Inc. based inCarlsbad, CALIFORNIA (USA)
COBRA PzF NCS is the world’s first non-drug eluting, nanocoated stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT ...